共 50 条
- [2] Pharmacokinetic bioequivalence of sitagliptin phosphate tablet formulations: a randomized, open-label, crossover study in healthy volunteers GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL, 2023, 12 (01):
- [3] Levocetirizine Oral Disintegrating Tablet: A Randomized Open-Label Crossover Bioequivalence Study in Healthy Japanese Volunteers CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2020, 9 (07): : 805 - 812
- [4] A Phase I, open-label, randomized, crossover study in healthy subjects to evaluate the bioavailability of, and the food effect on, a pomalidomide oral liquid suspension CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2018, 10 : 1089 - 1099
- [7] A Phase 1 Study to Evaluate the Bioequivalence of Oral Tablet and Orally Dissolving Tablet Formulations of Rimegepant in Healthy Adult Subjects Under Fasting Conditions HEADACHE, 2018, 58 (08): : 1303 - 1304
- [9] Apixaban Pharmacokinetics and Bioequivalence of Two Tablet Formulations: A Randomized, Open-Label, Crossover Study, Fasting Condition in Healthy Indonesian Volunteers CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2024, 13 (08): : 890 - 896
- [10] Pharmacokinetics and Bioequivalence of 2 Azithromycin Tablet Formulations: A Randomized, Open-Label, 2-Stage Crossover Study in Healthy Volunteers CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (09): : 1078 - 1083